# A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015)

> **NCT00631488** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 146 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** MK-0893
- **DRUG:** Sitagliptin
- **DRUG:** Metformin
- **DRUG:** Placebo for MK-0893
- **DRUG:** Placebo for Sitagliptin
- **DRUG:** Placebo for Metformin

## Key facts

- **NCT ID:** NCT00631488
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2017-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00631488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00631488, "A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015)". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00631488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*